semaglutide for mental health Novo Nordisk diabetes drug shows signs of improving patients' in a study Study: Some GLP-1s may lower

When youre placed on a GLP-1 medication, your provider should discuss your protein goals

Ozempic is FDA-approved for type 2 diabetes treatment, but may be prescribed off-label for weight loss at a healthcare providers discretion

It does not contain a GLP-1 receptor agonist

Semaglutide 2.4 mg once weekly in patients with NASH-related cirrhosis: a randomised, placebo-controlled, phase 2 trial

Semaglutide Fatigue Characteristics: Temporal relationship with treatment initiation or dose increases Gradual improvement over weeks to months Association with gastrointestinal side effects Response to supportive care measures Alternative Fatigue Causes to Consider: Underlying diabetes complications or poor glycemic control Sleep disorders or chronic sleep deprivation Thyroid dysfunction or other endocrine disorders Depression, anxiety, or other mental health conditions Iron deficiency anemia or other nutritional deficiencies Medication interactions with concurrent therapies Documentation and Assessment Approach: Maintaining detailed symptom logs helps healthcare providers distinguish between semaglutide-related fatigue and other potential causes